Valneva SE (VALN) Non-Current Debt (2020 - 2026)

Valneva SE (VALN) posted quarterly Non-Current Debt of $186.7 million for Q1 2026, up 1.6% year-on-year from $183.8 million in Q1 2025, and up 1.74% on a QoQ basis from $183.5 million in Q4 2025.

Valneva SE (VALN) Non-Current Debt (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Non-Current Debt for 7 consecutive years, with $186.7 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Debt rose 1.6% year-over-year to $186.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.7 million (up 1.6% YoY) and the FY2025 annual result came in at $183.5 million, down 3.16% from the prior year.
  • Non-Current Debt grew to $186.7 million in Q1 2026 per VALN's latest filing, from $183.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for VALN reached as high as $189.5 million in Q4 2024 and fell as low as $54.6 million in Q1 2022.
  • A 5-year average of $137.2 million and a median of $139.2 million in 2025 frame the typical range for Non-Current Debt.
  • Annual changes were most pronounced in 2024 — Non-Current Debt surged 116.33% — and 2025, when it fell 28.89%.
  • Year by year, Non-Current Debt stood at $99.3 million in 2022, then surged by 52.21% to $151.1 million in 2023, then climbed by 25.42% to $189.5 million in 2024, then retreated by 3.16% to $183.5 million in 2025, then rose by 1.74% to $186.7 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $186.7 million, $183.5 million, and $123.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 186.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 186.70 Mn
Dec 31, 2025 183.51 Mn
Sep 30, 2025 123.91 Mn
Jun 30, 2025 139.24 Mn
Mar 31, 2025 183.75 Mn
Dec 31, 2024 189.49 Mn
Sep 30, 2024 174.25 Mn
Jun 30, 2024 182.70 Mn
Mar 31, 2024 180.97 Mn
Dec 31, 2023 151.08 Mn
Sep 30, 2023 121.81 Mn
Jun 30, 2023 84.45 Mn
Mar 31, 2023 94.71 Mn
Dec 31, 2022 99.26 Mn
Sep 30, 2022 106.24 Mn
Jun 30, 2022 76.31 Mn
Mar 31, 2022 54.63 Mn
Dec 31, 2021 57.72 Mn
Dec 31, 2020 52.77 Mn